NCT04666714View on ClinicalTrials.gov

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

PHASE3RecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Neuropathic Pain
Interventions
DRUG

Praga formulation

Praga formulation tablet

OTHER

Placebo pregabalin 75mg

Placebo pregabalin 75mg tablet

OTHER

Placebo Pregabalin 150mg

Placebo Pregabalin 150mg tablet

DRUG

Pregabalin 75mg

Pregabalin 75mg tablet

DRUG

Pregabalin 150mg

Pregabalin 150mg tablet

OTHER

Placebo Praga formulation

Placebo Praga formulation tablet

Trial Locations (1)

13.084-791

RECRUITING

Allegisa, Campinas

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY